Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Merck KGaA, 3DP extend drug discovery agreement for another year

Oct. 5, 1998

Bayer, Millennium form the largest drug discovery alliance in history

Sep. 29, 1998

Tranzyme obtains technology license from U. of Alabama

Sep. 24, 1998

PowderJect delivery of DNA vaccines validated in preclinical study

Sep. 24, 1998

BTG licenses improved vaccine technology to Pasteur Merieux Connaught

Sep. 23, 1998

Lion and Infogen establish gene identification collaboration

Sep. 23, 1998

Genetronics reports continued success with electroporation therapy of cancer

Sep. 22, 1998

SB-234551 characterized as potent, selective, nonpeptide ETA receptor antagonist

Sep. 18, 1998

Nexell submits data requested by FDA

Sep. 18, 1998

First group 1 mGluR antagonist with submicromolar potency described by Lilly

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...